the market?
Ariad Pharmaceuticals, Inc.
NASDAQ: ARIA
19.57
0.13
(0.67%)
| Today's Open | $19.43 |
|---|---|
| Previous Close | $19.44 |
| Daily Range | $19.09 - $19.75 |
| 52-Week Range | $15.13 - $25.40 |
| Market Cap | $3.6B |
| P/E Ratio | -14.40 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,652,426 |
| Average Daily Volume | 3,179,475 |
| Current FY EPS | -$1.64 |
How do you think ARIA
will perform against the market?
Top ARIA Bull/Bear Pitches
JesusForgives (< 20)
Submitted
April 1, 2010
This stock could just be a good pick to do a cover call option for may10 if my figures are right you could see a return of 14% for the month.
zzlangerhans (< 20)
Submitted
December 2, 2010
Ariad's share price has bounced around a lot this year in advance of data from the phase III SUCCEED trial of ridaforolimus in metastatic sarcoma, and is now close to a three year high (and a six-year … More
News & Commentary
3 Humongous Health Care Stocks This Week
The major indexes might be tired after a great run this year, but these health-care stocks are sprinting ahead.Merck Stock Is a Good Investment (According to Merck)
Merck accelerates its buyback.Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Cancer research is big business, and it pays to know where research dollars are headed.What’s Moving These Biotech Stocks?
What’s Moving These Biotech Stocks?3 Companies That Put the "Tech" in "Biotech"
From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."Sector
Healthcare
Industry
Drugs
Ariad Pharmaceuticals, Inc. (ARIA) Description
The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/
